Home
About
Warning Letter Wednesday
Work With Me
Testimonials
Appearances
Press
Regulatory Blog
Resources
More
Asa Waldstein
Community, Compliance, Natural Health
Marketing Strategy Compliance √
Take FDA inquiries seriously
2/19/25
Small words can drastically increase claim risk
1/29/25
Amazon compliance still needs improving
1/9/25
Marketing strategies should consider “reasonable consumer expectations” to avoid issues
12/18/24
Nutrition fact panels must be in a compliant format
11/27/24
Following SOPs is essential to compliance
11/7/24
Playful ads can attract scrutiny
10/16/24
When will FDA go after “Nature’s Ozempic” claims
9/25/24
Ensure ESG claims are substantiated
2/12/25
Ensure 483 responses are complete
1/22/25
Trustpilot reviews can be “marketing”
1/1/25
Functional mushroom products under increased scrutiny
12/11/24
Free products should also be disclosed
11/20/24
Discussing ingredient benefits is "marketing"
10/30/24
Well intentioned marketing claims can turn products into high-risk regulatory categories
10/9/24
Do not over-explain clinical research
9/18/24
Small issues signify deeper noncompliance
2/5/25
Safety related product claims attract scrutiny
1/15/25
Be nice to FDA investigators & follow inspection SOPs
12/26/24
NAD challenge cases explored
12/4/24
Product reviews are marketing claims
11/13/24
Don’t engage with risky reviews
10/23/24
Learn from other’s mistakes
10/2/24
Blogs are “labeling”
9/11/24